CTRI Number |
CTRI/2025/03/082424 [Registered on: 17/03/2025] Trial Registered Prospectively |
Last Modified On: |
|
Post Graduate Thesis |
No |
Type of Trial |
Interventional |
Type of Study
|
Other (Specify) [Cosmetics] |
Study Design |
Single Arm Study |
Public Title of Study
|
Skin saftey test of Al Enaya Multiple Wet Wipes |
Scientific Title of Study
|
A Clinical Study to Evaluate the Skin Irritation Potential of Al Enaya Multiple Wet Wipes on Healthy Human Volunteers |
Trial Acronym |
NIL |
Secondary IDs if Any
|
Secondary ID |
Identifier |
CCFT528 Version 1.0 dated 24 Feb 2025 |
Protocol Number |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
Dr Robin Chugh |
Designation |
Principal Investigator |
Affiliation |
CCFT Laboratories |
Address |
1st Floor room 3, Skin testing lab , CCFT laboratories, AR multispecialty hospital and research center, Delhi Road
Meerut UTTAR PRADESH 250002 India |
Phone |
9027285265 |
Fax |
|
Email |
robinderm25@gmail.com |
|
Details of Contact Person Scientific Query
|
Name |
Puneet Mittal |
Designation |
Clinical Research Consultant |
Affiliation |
CCFT Laboratories |
Address |
1st Floor room 3, Skin testing lab , CCFT laboratories, AR multispecialty hospital and research center, Delhi Road
Meerut UTTAR PRADESH 250002 India |
Phone |
8937015757 |
Fax |
|
Email |
puneetmittal@mgcts.org |
|
Details of Contact Person Public Query
|
Name |
Puneet Mittal |
Designation |
Clinical Research Consultant |
Affiliation |
CCFT Laboratories |
Address |
1st Floor room 3, Skin testing lab , CCFT laboratories, AR multispecialty hospital and research center, Delhi Road
UTTAR PRADESH 250002 India |
Phone |
8937015757 |
Fax |
|
Email |
puneetmittal@mgcts.org |
|
Source of Monetary or Material Support
|
Al Enaya Wipes Packing LLC, Po Box 833314. Shop 2, 19H Anais, Al Sajah Industrial Sharjah, UAE |
CCFT Laboratories, First floor, 135, Delhi Rd, besides Ramleela ground, New Punjabi Pura, Meerut, Uttar Pradesh 250002 |
|
Primary Sponsor
|
Name |
Al Enaya Wipes Packing LLC |
Address |
Po Box 833314. Shop 2, 19H Anais, Al Sajah Industrial Sharjah, UAE |
Type of Sponsor |
Pharmaceutical industry-Global |
|
Details of Secondary Sponsor
|
Name |
Address |
Not Applicable |
Not Applicable |
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 1 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
Dr Robin Chugh |
CCFT laboratories |
First Floor, 135, Panjabipura, Besides Ramleela Ground, Delhi Road, Meerut UTTAR PRADESH |
9027285265
robinderm25@gmail.com |
|
Details of Ethics Committee
|
No of Ethics Committees= 1 |
Name of Committee |
Approval Status |
ARMHRC Institutional Ethics Committee |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
|
Health Type |
Condition |
Healthy Human Volunteers |
Not Applicable |
|
Intervention / Comparator Agent
|
Type |
Name |
Details |
Intervention |
Finn chamber |
Each patch contains 40 microgram/ microliter of 1.CareBaby wipes, 2. Trepure Natural Baby wipes, 3. Trepure Natural Makeup remover, 4. Trepure Natural Botanical Hyaluranic Tonner Wipes, 5. Trepure Natural deodrant wipes, 6. Negative control(0.9% NaCl, 7.Positive Control- 1% SLS) Route of Administration: Topical Frequency: Once Duration:24hrs |
Comparator Agent |
Not Applicable |
Not Applicable |
|
Inclusion Criteria
|
Age From |
18.00 Year(s) |
Age To |
65.00 Year(s) |
Gender |
Both |
Details |
1. Voluntary man or women between 18 and 65 years.
2. Phototype III to V.
3. Having apparently healthy skin on test area.
4. For whom the investigator considers that the compliance will be correct.
5. Cooperating, informed of the need and duration of the examinations and ready to comply with protocol procedures.
6. Having signed a Consent Form.
7. Willingness to avoid intense UV exposure on test site (sun or artificial UV) during the course of the study.
8. Willingness to avoid excessive water contact (for example swimming) or activity which causes excessive sweating (that is exercise, sauna), during the course of the study.
9. Should be able to read and write (in English, Hindi or local language).
10. Having valid proof of identity and age. |
|
ExclusionCriteria |
Details |
1. Pregnant or nursing mothers
2.Scars, excessive terminal hair or tattoo on the studied area
3.Henna tattoo anywhere on the body (in case of studies involving
hair dyes)
4.Dermatological infection or pathology on the level of studied area
5.Hypersensitivity, allergy antecedent (to any cosmetic product, raw
material or hair dye)
6.Any clinically significant systemic or cutaneous disease, which may
interfere with study treatment or procedures
7.Chronic illness which may influence the outcome of the study
8.Subjects on any medical treatment either systemic or topical which
may interfere with the performance of the study treatment (presently
or in the past 1 month)
9.Subject in an exclusion period or participating in another food, cosmetic or therapeutic trial. |
|
Method of Generating Random Sequence
|
Not Applicable |
Method of Concealment
|
Not Applicable |
Blinding/Masking
|
Open Label |
Primary Outcome
|
Outcome |
TimePoints |
Change in Skin Irritation Score-erythema & oedema |
Day 0, Day 2 and Day 8 |
|
Secondary Outcome
|
Outcome |
TimePoints |
Not Applicable |
Not Applicable |
|
Target Sample Size
|
Total Sample Size="30" Sample Size from India="30"
Final Enrollment numbers achieved (Total)= "0"
Final Enrollment numbers achieved (India)="0" |
Phase of Trial
|
N/A |
Date of First Enrollment (India)
|
26/03/2025 |
Date of Study Completion (India) |
Date Missing |
Date of First Enrollment (Global) |
Date Missing |
Date of Study Completion (Global) |
Date Missing |
Estimated Duration of Trial
|
Years="0" Months="0" Days="15" |
Recruitment Status of Trial (Global)
|
Not Applicable |
Recruitment Status of Trial (India) |
Completed |
Publication Details
|
N/A |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
Brief Summary
|
The below products would be tested as per the guideline ISO 10993 Part23 for dermal safety assessment.
- Care Baby Wipes
- Trepure Natural Baby Wipes
- Trepure Natural Makeup Remover Wipes
- Trepure Natural Botanical Hyaluronic Toner Wipes
- Trepure Natural Deodrant Wipes
The product will be tested for skin irritation on 30 human volunteers. Assessment would be done on day 0, day 2, with followup visit on day 8 for erythema and Oedema scoring |